DocGo (DCGO) Stock Price, News & Analysis

Company Overview

DocGo Inc. (NASDAQ: DCGO) is a healthcare technology and services company that delivers medical care and patient-support services outside traditional healthcare facilities. Its platform combines mobile medical teams, technology, logistics and data-driven care coordination to help healthcare providers, government agencies and other organizations reach patients in their homes, workplaces and communities.

The company’s services have included mobile health services, non-emergency medical transportation, remote patient monitoring, community-based clinical care, COVID-19 testing and vaccination programs, and assistance with patient engagement and care navigation. DocGo also provides transportation and related support intended to help patients access medical appointments and other healthcare services.

DocGo was formerly known as Ambulnz and began operating under the DocGo name after expanding beyond medical transportation into broader mobile healthcare services. The company serves customers primarily in the United States and has also reported operations in the United Kingdom. Its business is organized around providing flexible, technology-enabled care and support in settings beyond hospitals and doctors’ offices.

Key Stats

• Today's Range: $0.29 to $0.32
• 50-Day Range: $0.31 to $0.71
• 52-Week Range: $0.29 to $1.65
• Volume: 340,888 shs
• Average Volume: 858,176 shs
• Market Capitalization: $29.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.38
• Consensus Rating: Hold

DocGo Stock Analysis - MarketRank™

DocGo scored higher than 77% of companies evaluated by MarketBeat, and ranked 150th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

DocGo has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

DocGo has a consensus price target of $2.38, representing about 678.4% upside from its current price of $0.31.

Amount of Analyst Coverage

DocGo has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for DocGo are expected to grow in the coming year, from ($0.22) to ($0.06) per share.

Price to Book Value per Share Ratio

DocGo has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.12% of the float of DocGo has been sold short.

Short Interest Ratio / Days to Cover

DocGo has a short interest ratio ("days to cover") of 2.63, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in DocGo has recently decreased by 27.87%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

DocGo does not currently pay a dividend.

Dividend Growth

DocGo does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

DocGo has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for DocGo this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, DocGo insiders have not sold or bought any company stock.

Percentage Held by Insiders

5.10% of the stock of DocGo is held by insiders.

Percentage Held by Institutions

56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/17/2026
• Today: 10/14/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:DCGO
• CIK: 1822359
• Web: www.docgo.com
• Phone: 844-443-6246
• Fax: N/A
• Employees: 3,568
• Year Founded: N/A

Price Target and Rating

• Average Price Target for DocGo: $2.38
• High Price Target: $3.00
• Low Price Target: $1.00
• Potential Upside/Downside: +713.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.96)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$182.40 million
• Net Margins: -65.29%
• Pretax Margin: -64.26%
• Return on Equity: -40.42%
• Return on Assets: -24.81%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.66
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: $322.20 million
• Price / Sales: 0.09
• Cash Flow: $0.05 per share
• Price / Cash Flow: 6.03
• Book Value: $1.28 per share
• Price / Book: 0.23

Miscellaneous

• Outstanding Shares: 98,930,000
• Free Float: 93,883,000
• Market Cap: $28.89 million
• Optionable: Optionable
• Beta: 0.97